This information was originally presented at the NCCN 21^st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.

The NCCN 2016 Oncology Nursing Program Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

These NCCN Guidelines Insights highlight the important updates/changes specific to the 2016 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma.

NCCN Evidence Blocks™ are intended as a visual representation of five key measures that provide important information about specific recommendations contained within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).

This information was originally presented at the NCCN 10^th Annual Congress: Hematologic Malignancies™ held in San Francisco, California.

This information was originally presented at the NCCN 10^th Annual Congress: Hematologic Malignancies™ held in San Francisco, California.

Immune therapy has emerged as a promising area of cancer therapeutics based on its potential for tumor selectivity and targeting of chemotherapy-resistant clones. Allogeneic transplantation produces durable remissions in a subset of patients, albeit at the cost of graft-versus-host disease.

Join Kenneth Anderson, MD and Paul Richardson, MD as they present their multidisciplinary expertise on a range of cases pertaining to multiple myeloma.

This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

Join Kenneth Anderson, MD and Paul Richardson, MD as they present their multidisciplinary expertise on a range of cases pertaining to multiple myeloma.